FDA meeting on September 20-21, 2016

Posted in Latest News on September 23, 2016.

pharmacy-pic2

On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of the FDA and the states. The meeting provided an opportunity to discuss each state’s regulatory framework, recent FDA guidance documents, changes to the FDA’s inspection procedures, and information sharing challenges and opportunities.



More Latest News

Attention Pharmacists: Florida HB423
March 13, 2017

ARNP’s and PA’s, if you have questions regarding the Florida House Bill 423 and how it affects you, this free, informative webinar is for you! Continue reading


Imagineering the Future of Pharmacy Regulation
March 2, 2017

The boards of pharmacy will elect officers and members of the NABP Executive Committee, review and vote on NABP policies, and guide the direction of the Association Continue reading